Search by Drug Name or NDC

    NDC 00363-4069-02 Lansoprazole 15 mg/1 Details

    Lansoprazole 15 mg/1

    Lansoprazole is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Walgreen Company. The primary component is LANSOPRAZOLE.

    Product Information

    NDC 00363-4069
    Product ID 0363-4069_c83549f5-fc2d-47c0-ab94-b64d017bfd48
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Lansoprazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lansoprazole
    Product Type HUMAN OTC DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 15
    Active Ingredient Units mg/1
    Substance Name LANSOPRAZOLE
    Labeler Name Walgreen Company
    Pharmaceutical Class Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202319
    Listing Certified Through 2023-12-31

    Package

    NDC 00363-4069-02 (00363406902)

    NDC Package Code 0363-4069-02
    Billing NDC 00363406902
    Package 2 BOTTLE in 1 CARTON (0363-4069-02) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
    Marketing Start Date 2018-06-26
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL fbdec940-9215-42af-a309-d191f57ce254 Details

    Revised: 4/2020